Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Commodities
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Profound Medical Corp
T.PRN
Alternate Symbol(s):
PROF
Healthcare
Medical Devices
Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. TULSA-PRO is designed...
to provide customizable and predictable radiation-free ablation of a surgeon-defined prostate volume while protecting the urethra and rectum. TULSA-PRO has the potential to be a flexible technology in customizable prostate ablation, including intermediate stage cancer, localized radio-recurrent cancer, retention and hematuria palliation in locally advanced prostate cancer and the transition zone in large volume benign prostatic hyperplasia. It is also commercializing Sonalleve, which is a therapeutic platform for the treatment of uterine fibroids and palliative pain treatment of bone metastases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:PRN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(11)
•••
HomerAndCompany
X
View Profile
View Bullboard History
Comment by
HomerAndCompany
on Oct 04, 2021 10:03am
RE:RE:Target 25 installations by YE, up from 14 as of Q2 Conf Call
My understanding from the Q2 conference call was that they had 14 sites giving treatments at that time, with a target of 25 sites giving treatments by the end of 2021. Not all of the 20 sites you list
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Oct 02, 2021 11:11pm
Strong Buy at Raymond James ...
https://www.cantechletter.com/2021/10/profound-medical-is-a-strong-buy-says-raymond-james/
C.RVV Announces Type C Meeting Request Granted by FDA for Clinical Study
posted Apr 24, 2024 9:00am by
Revive Therapeutics Ltd.
-
|
Currently, the Company is exploring the use of Bucillamine as a potential treatment for long COVID. The Company is advancing the clinical development of Bucillamine by leveraging the published research and data from its previous Phase 3 clinical trial (the “Study”) and is finalizing the regulatory and clinical package that includes a proposed clinical study for long COVID to present to the FDA ...read more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Oct 02, 2021 9:03pm
RE:Target 25 installations by YE, up from 14 as of Q2 Conf Call
Not sure I understand the numbers ... - 11 Procedure Centers in USA (one of them doubles as a learning center) - 1 additional learning center - 7 in Europe - 1 in Japan That's 20 in total Are
...more
(11)
•••
HomerAndCompany
X
View Profile
View Bullboard History
Post by
HomerAndCompany
on Sep 28, 2021 9:25am
Target 25 installations by YE, up from 14 as of Q2 Conf Call
This increase in the rate of installations is to be facilitated by doubling the size of sales and installation teams by Q4. .
(11)
•••
HomerAndCompany
X
View Profile
View Bullboard History
Post by
HomerAndCompany
on Sep 21, 2021 7:26am
Current Procedural Terminology 1 Code application in 2022
In the remainder of 2021 Profound is doing the ground work for a CPT 1 code application (as per Q2 conf call). The CPT 1 code is important for government reimbursement for the treatments. Just
...more
(11)
•••
HomerAndCompany
X
View Profile
View Bullboard History
Post by
HomerAndCompany
on Sep 18, 2021 8:32am
Profound to Double Size of Sales & Installation Teams by Q4
As per the Q2 conference call Aug4, 2021. So we should see a faster rate of new installations as well as more treatments per site at existing installations accelerating PRN on the path to
...more
(11)
•••
HomerAndCompany
X
View Profile
View Bullboard History
Comment by
HomerAndCompany
on Aug 19, 2021 4:54pm
RE:Research Capital: Take a pass on Profound Medical
"In spite of the potential rebound and the prospect of third quarter results coming in November, Uddin believes Profound is still a wait-and-see prospect. With the update, Uddin has maintained
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Aug 11, 2021 1:36am
Welcome ...
Welcome HALO Diagnostics out of Houston, Tx. It's been a while since we added one. Nice !
(5994)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Aug 06, 2021 6:36am
Top Gainers
Symbol/ Company Price $ Change $ Volume Data delayed at least 15 minutes, as of 05/08/2021 4:00 PM ET | All market data delayed
...more
(77)
•••
ChupacabraBueno
X
View Profile
View Bullboard History
Comment by
ChupacabraBueno
on Aug 01, 2021 5:49pm
RE:nice target
Director(s) and CEO have bought about $520,000 worth since mid-May. That is dwarfed by earlier selling by the CFO. Anyone know what Aaron Davidson needed $4 million for? Anyway, many reasons to sell,
...more
(4)
•••
rocko65
X
View Profile
View Bullboard History
Post by
rocko65
on Jul 29, 2021 11:13am
nice target
but obviously mr market thinks differently! i love this company and have put my money where my mouth is, maybe management should show some love also and buy
(5994)
•••
retiredcf
X
View Profile
View Bullboard History
Post by
retiredcf
on Jul 29, 2021 10:31am
Nice Target
Perhaps a client could post the report. GLTA Profound Medical Reiterated by Raymond James C$18.69 +0.1% C$45.00 Strong-Buy
(11)
•••
HomerAndCompany
X
View Profile
View Bullboard History
Comment by
HomerAndCompany
on Jul 03, 2021 9:38am
RE:Insider Buying
Latest insider public market buy: June 22 (no selling since March) by Director Murielle Lortie, establishing a new position with 880 shares bought at $22.75. Insider buys is recent months are still
...more
(2)
•••
Charlie263
X
View Profile
View Bullboard History
Comment by
Charlie263
on Jul 02, 2021 11:39am
RE:RE:Dr Arun recently had TULSA
The case for TULSA is promising. It's target patient base in just US is 500k approx. Assuming it just tap in 25% of market i.e. 125,000 patients per year by 2025...that will bring this company to
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Jun 30, 2021 9:40am
RE:Dr Arun recently had TULSA
Funny Charlie ... just saw that for the first time yesterday. I didn't realize he was being emotional ... thought he was sick and coughing. Then I realized he was holding back tears. Gotta admit
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover a Green Resources Stock Scoring Record Quarterly Growth
Stage Set for Creation of a Leading Intermediate Gold Producer
Revive Therapeutics Announces Type C Meeting Request Granted by FDA for Clinical Study